NASDAQ OMX

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer

Dela

YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung cancer and improve quality of life for lung cancer patients.

Innovations in lung cancer treatment linked to the discovery of PD-1
Prof. Tasuku Honjo of Japan, who was the first to identify PD-1 in 1992, shared an update on how PD-1 blockers have been widely used to treat many types of cancers. After decades of study, research into PD-1 has led to breakthrough immunotherapy treatments that are being hailed as a "penicillin moment" in cancer treatment.

"I believe that, just as a number of antibiotics developed in the wake of the discovery of penicillin now protect humans against threats of infectious diseases, this discovery will play a leading role in advancement of cancer immunotherapy," said Prof. Honjo. "In the future, the fear of dying from cancer will cease to exist."

Extensive research into combination therapy has been undertaken by a number of institutions. Specifically, Prof. Honjo felt that PD-1 blockade combinatorial therapy using mitochondrial activators, especially PGC-1(alpha) activators, may be promising.

International Association for the Study of Lung Cancer Blueprint II
Dr. Fred Hirsch of the United States and Dr. Ming Tsao of Canada shared an exciting update on Phase 2 of the PD-L1 Blueprint Project.

The project began in 2014 during a workshop led by the U.S. Food and Drug Administration (FDA), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). As a result of the workshop, the PD-L1 Blueprint Project was established, with the primary goal of comparing the PD-L1 assays used in clinical trials in terms of analytical and diagnostic performance. The consortium behind the Blueprint Project included representatives from Bristol-Myers Squibb (BMS), Merck, Genentech/Roche, AstraZeneca, Dako, Ventana and AACR, as well as the IASLC, which is coordinating the project.

"In the new era of immunotherapy in thoracic cancer, evaluating PD-L1 status remains a clinical challenge," said Dr. Hirsch. "The major strength of the PD-L1 Blueprint Project is the unique partnership among the different pharmaceutical companies and diagnostic companies, with the IASLC as the coordinating organization."

The Blueprint phase 1 comparability study demonstrated that three PD-L1 assays (28-8, 22C3, SP263) showed comparable analytical performance for assessment of PD-L1 expression on tumor cells, while the SP-142 PD-L1 assay appeared to stain a lower percentage of tumor cells compared to the other assays. In contrast, all assays stained tumor infiltrating immune cells, but with poor concordance between assays. The Blueprint phase 2 study involving routine clinical lung cancer samples and 25 pathologists largely affirms the blueprint 1 results, thus three of the PD-L1 assays, 22C3, 28-8 and SP263 are comparable for tumor cell staining. The results also showed that pathologists are strongly reliable in scoring the PD-L1 expression on tumor cells, and scoring by glass slides and digital images are comparable.  

Community engagement interventions may reduce disparities in lung cancer outcomes among minorities
Community-based interventions implemented in minority community sites resulted in changes in participants' knowledge, attitudes and beliefs about cancer, as well as perceived benefits and self-efficacy measures regarding lung cancer screening, as uncovered in research presented by Dr. Lovoria Williams of August University in the United States. These findings are critical to addressing the significant lung cancer survival rate disparities in racial and ethnic minorities and the medically underserved. Read the full press release here.

Exercise interventions in advanced lung cancer patients led to increased functionality, which may be linked to quality of life benefits
Physical exercise and psycho-social interventions in patients with advanced stage lung cancer improved functional capacity, which may be linked to quality of life benefits. The exercise group was found to have improved functional capacity at the conclusion of the intervention and reported a significant improvement in quality of life, which may be linked to the improved functionality, according to Dr. Morten Quist of the University of Copenhagen in Denmark. To read the full press release, click here.

Livestreams of the daily press conferences are available here.

About the WCLC
The World Conference on Lung Cancer (WCLC) is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting over 6,000 researchers, physicians and specialists from more than 100 countries. The goal is to disseminate the latest scientific achievements; increase awareness, collaboration and understanding of lung cancer; and to help participants implement the latest developments across the globe. Organized under the theme of "Synergy to Conquer Lung Cancer," the conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2017.iaslc.org.

About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Contacts:
Hillary Wasserman
Senior Associate
HWasserman@GroupGordon.com   
+1 732-778-1896

Becky Bunn, MSc
Public Relations Manager
Becky.Bunn@IASLC.org 
+1 720-254-9509




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IASLC via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Hoylu AB: Hoylu VD ökar ägande23.5.2018 08:30Pressmeddelande

Malmö, Sverige, 23 maj 2018 - Hoylu VD, Stein Revelsby har köpt 200 000 aktier (cirka 1,3%) i Hoylu till ett genomsnittspris på 4,31 per aktie. Hans totala innehav per 23 maj är 518 975 aktier och 625 900 optioner. För mer information, kontakta: Stein Revelsby, VD Hoylu +1 213 440 2499 Email: sr@hoylu.com Karl Wiersholm, CFO Hoylu +1 425 829 2316 Email: kw@hoylu.com Om Hoylu Hoylu är ett innovativt företag som levererar lösningar för digitala arbetsytor. Hoylu Suite är det oumbärliga verktyget som möjliggör för företag att leverera högkvalitativt samarbete på den moderna arbetsplatsen med funktionen att använda vilken enhet som helst, för att arbeta smartare och roligare inom olika branscher som såsom teknik, läkemedel, konstruktion, entreprenad, tillverkning, resor, gästfrihet, grafisk design och många fler. Kortnamn: Hoylu Marknadsplats: Nasdaq First North Stockholm Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550 Publicering Denna information lämnades, genom ovanstå

Hoylu AB: Hoylu CEO increases ownership23.5.2018 08:30Pressmeddelande

Malmo, Sweden, May 23, 2018 - Hoylu CEO, Stein Revelsby has purchased 200,000 shares (approximately 1.3%) in Hoylu at an average price of SEK 4.31 per share. His total holding per May 23 is 518,975 shares and 625,900 options. For more information, please contact: Stein Revelsby, CEO Hoylu + 1 213 440 2499 Email: sr@hoylu.com Karl Wiersholm, CFO Hoylu + 1 425 829 2316 Email: kw@hoylu.com About Hoylu Hoylu delivers innovative solutions to allow global collaborative teams plan, create and share information that will enrichen the user experience in the virtual office. The Hoylu Suite delivers a comprehensive set of personalized digital workspaces to enable teams across locations, on any device, to work smarter and with more fun across major industries including Engineering, Education, Pharmaceutical, Construction, Manufacturing, Graphic Design and many more. For more information visit: Www.hoylu.com or Www.introduce.se/foretag/hoylu Ticker: Hoylu Marketplace: Nasdaq First North Stockholm C

DealCloud announces global expansion, opening of EMEA Headquarters23.5.2018 08:00Pressmeddelande

LONDON, May 23, 2018 (GLOBE NEWSWIRE) -- DealCloud, a technology leader for deal & relationship management in the private capital markets, announces the opening of its EMEA headquarters in Holborn, London, United Kingdom. With the opening of the regional headquarters in London, DealCloud operates out of 4 offices globally. Supporting a rapidly growing client base in the region, DealCloud now provides implementation services, client support, and account management through a dedicated team based out of the London office. "We work closely with every client to tailor our exceptional technology and capabilities to their specific process," says DealCloud Co-Founder and Chief Revenue Officer Ben Harrison. "We are committed to delivering the best possible results for our clients, and we believe growing our team in London is the best way to do this." "Supporting dozens of clients in EMEA today, and adding new clients every week, we are excited about the impact our office expansion will have wit

BIMobject AB: BIMobject acquires Dubai Media City-based social media platform The BIM Hub23.5.2018 08:00Pressmeddelande

BIMobject AB, listed at Nasdaq First North, has today acquired all companies that are part of The BIM Hub Group. The group is based in Dubai, United Arab Emirates, and in England. BIMobject takes over some employees, customer agreements, technical platforms, domains, trademarks and all customer data as well as relationships on thebimhub.com . The BIM Hub is a privately-owned web platform with operations in Dubai, United Arab Emirates, and West Yorkshire, England. The BIM Hub is a professional social media platform for BIM users, property owners, architects, engineers and contractors as well as project managers, property managers and facility managers. The platform's focus is to offer content such as educational materials, presentations, standards, white papers, videos, news, and events. In addition, there are various forums adapted for the construction industry, working with or in connection with the emerging BIM industry. The BIM Hub is advertising-funded, but BIMobject's intention is

BIMobject AB: BIMobject förvärvar sociala medier-plattformen The BIM Hub med huvudkontor i Dubai Media City23.5.2018 08:00Pressmeddelande

BIMobject AB (publ), noterat vid Nasdaq First North, har idag förvärvat samtliga bolag som ingår i The BIM Hub group med bas i Dubai, Förenade Arabemiraten och i England. Bolaget övertar viss personal, kundavtal, teknisk plattform, domäner, varumärken och all kunddata samt relationer på sociala medier-plattformen thebimhub.com . The BIM Hub är en privatägd webbplattform med verksamhet i Dubai, Förenade Arabemiraten, och West Yorkshire i England. The BIM Hub är en professionell sociala medier-plattform som samlar BIM-användare, fastighetsägare, arkitekter, ingenjörer och byggentreprenörer samt projektledare och fastighets- och anläggningsförvaltare. Plattformens fokus är att erbjuda innehåll som exempelvis utbildningsmaterial, presentationer, standards, white papers, videos samt nyheter och event. Därtill finns olika forum anpassat för byggindustrin som arbetar med eller i anslutning till den framväxande BIM-industrin. The BIM Hub är reklamfinansierad men BIMobjects avsikt är att snaras

Northland Power Announces Retirement of CEO John Brace and Appointment of Mike Crawley as Chief Executive Officer, Effective August 4, 201823.5.2018 01:27Pressmeddelande

TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. ("Northland") (TSX:NPI) today announced that Chief Executive Officer John Brace will retire on August 4, 2018 after 30 years with the company. Mike Crawley, currently Northland's Executive Vice President, Development has been appointed to the role of Chief Executive Officer, effective August 4, 2018. Mr. Brace and Mr. Crawley will work together to ensure a smooth transition. Mr. Brace will continue to serve as a Director of Northland. John joined Northland in 1988, shortly after the company was founded. He was appointed Chief Executive Officer in 2005. He has steered Northland through many of its projects, initiatives and growth. Under his leadership, the company has grown to its current enterprise value of $12 billion. John was appointed to Northland's Board of Directors on April 4, 2018, and along with Northland's other board members, will stand for re-election at Northland's Annual General Meeting on May 23rd, 2018. Mike

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum